Bonus shares 2024: Remedium Lifecare share price hits 20% upper circuit
Fri, Jul 5, 2024 10:55 AM

Bonus shares 2024: Remedium Lifecare share price hits 20% upper circuit

A Flip by Riya Sharma
Get it on Google Play
Remedium Lifecare's board of directors has fixed July 6, 2024, as the record date for issuing bonus shares in a 3:1 ratio. The company's share price rose 20% to ₹20.92 per share on the last trading session ahead of the record date. Remedium Lifecare also plans to raise ₹200 crore through a qualified institutional placement (QIP) to finance acquisitions in the pharmaceutical industry.

More great flips

Stocks to buy: BHEL and CDSL among top picks; here’s why

Stocks to buy: BHEL and CDSL among top picks; here’s why

The Indian stock market's Nifty and Bank Nifty indices are trending upward, with support at 24200 and 52000, respectively. A break above 24400 could lead to a rally towards 24600/24800. Three stocks are recommended for buying: 📌BHEL at ₹316 with a target price of ₹340, 📌CDSL on dips around ₹2250 with a target price of ₹2600, and 📌Borosil at ₹500-515 with a target price of ₹580.

Open Flip
Better Megacap Stock: Nvidia vs. Microsoft

Better Megacap Stock: Nvidia vs. Microsoft

Nvidia and Microsoft, two megacap stocks, have seen significant growth in 2024. Nvidia's market cap has surged $2.7 trillion, largely due to demand for artificial intelligence (AI) and graphics processing units (GPUs). Microsoft has also performed well, integrating AI into its software and boasting diverse business segments. With Nvidia's price-to-sales ratio at 39x and Microsoft's at 14x.

Open Flip
2 Biotech Stocks With Big FDA Decisions Approaching – Here’s Analysts View

2 Biotech Stocks With Big FDA Decisions Approaching – Here’s Analysts View

Biotech stocks 📌Ascendis Pharma (ASND) and 📌Citius Pharmaceuticals (CTXR) offer significant upside potential, according to analysts. ASND's Skytrofa revenue grew 106% year-over-year, and its TransCon PTH drug has a multi-billion euro commercial opportunity. The stock has a Strong Buy consensus rating and a $183.38 average target price, suggesting a 35% gain.

Open Flip

Join our Smart Investment Community

More than 2 Million users are using FlipItMoney to stay updated about the business and finance world! Join FlipItMoney now and take smart investment decisions!
Icon